RxDoctor Payments Data

Armeghan Bagherpour

Physician Assistant · Sacramento, CANPI 1295390672

Payments from drug & device makers

$4,216in general payments, 2019–2025

Across 228 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$612
  • AstraZeneca$602
  • Amgen$475
  • Novartis$431
  • E.r. Squibb & Sons, L.L.C.$409
  • Johnson & Johnson$407
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,05296%
  • Education$1644%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,216 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban191$135,095
XareltoRivaroxaban150$114,231
JardianceEmpagliflozin121$98,158
FarxigaDapagliflozin Propanediol89$78,415
EntrestoSacubitril/Valsartan39$32,835
WegovySemaglutide13$18,388
Repatha SureclickEvolocumab27$15,787
VerquvoVericiguat15$10,776
DapagliflozinDapagliflozin Propanediol12$8,114
BrilintaTicagrelor14$7,658
Metoprolol Succinate164$3,344
Atorvastatin Calcium112$1,363
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide41$1,228
Rosuvastatin Calcium76$1,169
Nitroglycerin31$890

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$135,095191 claims
Johnson & JohnsonXarelto$407$114,231150 claims
Boehringer IngelheimJardiance$612$98,158121 claims
AstraZenecaFarxiga, Brilinta$602$86,073103 claims
NovartisEntresto$431$32,83539 claims
Novo NordiskWegovy$182$18,38813 claims
MerckVerquvo$235$10,77615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →